Bevacizumab for ocular neovascular diseases: a systematic review
Andriolo, Regis Bruni; Puga, Maria Eduarda; Belfort Júnior, Rubens; Atallah, Álvaro Nagib.
Säo Paulo med. j
; 127(2): 84-91, May 2009. ilus, tab, graf
Artigo em Inglês | LILACS | ID: lil-518407
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.
WITHDRAWN: Ozone therapy for the treatment of dental caries.
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
[Characterization of chosen pro-angiogenic factors and anti-angiogenic therapies in ovarian cancer].
Interventions for hand eczema.
Ranibizumab for the Treatment of Diabetic Macular Oedema in the Real-World Clinical Setting in Portugal: A Multicentre Study.
Herbal medicinal products or preparations for neuropathic pain.
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents.